Explore
0
0
Following
0
0
Notifications
0
0
Messages
0
0
History
0
0
Favorites
0
0
Rewards
0
0
About
Contact Us
Agreement
Privacy
©
2023 32Plus CO.,LTD.
History
Clear
Try to search for users or keywords
View results for "
"
Register
Sign In
CASI-Pharmaceuticals-凯信远达
PT
Lv
2
2023-5-12 11:20
· contributed a column
From China
Follow
Column
CASI合作伙伴BIOINVENT宣布BI-1206获美国FDA孤儿药资格认定 治疗滤泡性淋巴瘤
2022年1月20日,CASI宣布,其合作伙伴BioInvent International AB(以下简称BioInvent)旗下抗FcyRllB抗体BI-1206获得美国食品药品监督管理局(FDA)授予的孤儿药资格认定(Orphan Drug Designation, ODD),用于治疗滤泡性淋巴瘤(Follicular Lymphoma,FL)。
1,016
6
Repost
6
90
Please
Sign In
to post a comment~
Loading...
CASI-Pharmaceuticals-凯信远达
CASI Pharmaceuticals, Inc. is a NASDAQ-listed biopharmaceutical company.
Followers
28
Feed
10
View Zone